Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta

Details for Australian Patent Application No. 2009313562 (hide)

Owner Tezapsidis, N. Smith, M. Greco, S.

Inventors Tezapsidis, Nikolaos; Greco, Steven J.; Smith, Mark

Agent Spruson & Ferguson

Pub. Number AU-A-2009313562

PCT Pub. Number WO2010/054017

Priority 61/186,102 11.06.09 US; 61/111,197 04.11.08 US

Filing date 4 November 2009

Wipo publication date 14 May 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/054017 Priority application(s): WO2010/054017

28 June 2012 Amendment under Section 215, Death of the Applicant

  The name of the applicant has been amended from Mark Smith to Tezapsidis , N. ; Greco , S. ; Smith , G.

1 November 2012 Assignment before Grant

  Smith, Gemma; Greco, Steven; Tezapsidis, Nikolaos The application has been assigned to Neurotez, Inc.; Smith, Gemma

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313565-[4-(6-fluoro-7-methylamino-2,4-dioxo-1, 4-dihydro-2H-quinazolin-3-yl) - phenyl]-5-chloro-thiophen-2-yl-sulfonylu rea salts, forms and methods related thereto

2009313561-Detecting and monitoring left ventricular hypertrophy and congestive heart failure by profiling biomarkers